HOME >> BIOLOGY >> NEWS
Relative of snake venom toxin may aid in understanding nicotine addiction

March 18, 2002 -- Scientists have found that a protein resembling snake venom neurotoxin modulates the sensitivity of specific receptors in the brain that are targets of nicotine, the primary addictive drug in tobacco. The researchers say that the protein, lynx1, may be a new tool with which to probe how nicotine and other drugs activate pleasure centers of the brain.

Although studies of lynx1 and other members of this intriguing prototoxin protein family are still in the early stages, the researchers say they may help in understanding nicotine addiction or possibly human genetic diseases caused by defective prototoxins.

Howard Hughes Medical Institute investigatorNathaniel Heintz and his colleagues Ins Ibaez-Tallon and Julie Miwa at The Rockefeller University and colleagues at The Mayo Foundation and Columbia University reported in the March 14, 2002, issue of the journal Neuron that lynx1 is an interesting new modulator of nicotinic acetylcholine receptors.

Julie Miwa, a member of Heintzs laboratory and co-author of the Neuron article, first discovered lynx-1 in 1999. The discovery was especially intriguing, said Heintz, because it confirmed that mammals harbored a natural, or endogenous, protein resembling snake venom that could affect the nervous system. At the time the discovery was made, such an assumption was scientifically risky, said Heintz.

It was an appealing hypothesis that there might be an endogenous neurotoxin-like molecule that regulated some sort of receptor in the nervous system, said Heintz. But Julie was very, very brave to pursue this gene and its protein product on such a flimsy basis.

Miwas initial work showed that lynx1 was concentrated in the nervous system. Additional studies in collaboration with Ibaez-Tallon showed that lynx-1 altered the function of nicotinic acetylcholine receptors. Acetylcholine is a neurotransmitt
'"/>

Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
18-Mar-2002


Page: 1 2 3

Related biology news :

1. Relatives of Parkinsons patients have higher risk for action tremor
2. Relatives Of People with Colorectal Polyps Face Increased Risk For Colorectal Cancer
3. Scientists discover where snakes lived when they evolved into limbless creatures
4. Venom hunt finds harmless snakes a potential danger
5. UGA student questions why snakes cross roadways
6. Sea snake homing instinct could nix translocation
7. Lazy snakes! Pythons can be couch potatoes, too
8. U of C researcher tracks path of flying snake
9. Just one bite at a time: Researchers find snake with unusual feeding habit
10. Unique feeding behavior discovered for snakes
11. Ambushing prey may make snakes vulnerable

Post Your Comments:
(Date:5/24/2013)... one French Quarter neighborhood of New Orleans to determine ... Hurley, PhD, Assistant Professor of Audiology at LSU Health ... LSUHSC doctor of audiology student, recommend that people use ... case study is published online in the current issue ... important part of an audiologist,s practice is aiding patients ...
(Date:5/23/2013)... Tomatoes, said to be the world,s most popular fruit, ... UK research with purple GM varieties. , "Working ... only by the addition of a specific compound, allows ... traits," said Professor Cathie Martin from the John Innes ... varieties with better flavour, health and shelf life characteristics ...
(Date:5/23/2013)... estrogen suppresses lipid synthesis in the liver, UC Irvine ... certain liver diseases. , With this finding, Dr. ... views in the field. Study results appear in the ... . , "The dogma in the steroid receptor field ... in the nucleus respond to steroid hormones by regulating ...
Breaking Biology News(10 mins):Please do try this at home 2The world's favorite fruit only better-tasting and longer-lasting 2UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2
(Date:5/23/2013)... , May 23, 2013 BioTrends Research ... advisory firms for specialized biopharmaceutical issues, finds that, ... infectious disease specialists reported that in the past ... intentionally delaying treatment) in anticipation of the next ... months ago, when only 6 percent reported that ...
(Date:5/23/2013)... , May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... developing DCVax ® personalized immune therapies for solid ... exhibit at this year,s American Society Of Clinical Oncology ... highlight its leadership role in immune therapy.  ... annual meeting is the pre-eminent conference focused on clinical ...
(Date:5/23/2013)... May 23, 2013  Verenium Corporation (Nasdaq: ... the development and commercialization of high-performance enzymes, today announced ... Officer, will present at two upcoming conferences. ... present at the Second Annual Marcum LLP Microcap Conference ... Hotel in New York City.  The presentation is scheduled ...
(Date:5/23/2013)... SynCardia Systems, Inc. ( http://www.syncardia.com ), ... Canada and CE (Europe) approved Total Artificial Heart, announced ... boasts more than 380,000 visitors annually, is featuring the ... the Freedom® portable driver as part of its $3 ... of its kind. , “BodyWorks combines the latest ...
Breaking Biology Technology:The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Verenium To Present At Two Upcoming Conferences 2Verenium To Present At Two Upcoming Conferences 3SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 2SynCardia Total Artificial Heart Featured in $3 Million Exhibition at Glasgow Science Centre 3
Cached News: